Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Small and mid caps in favour today
Tue, 23 Sep 11:30 am

After opening flat, Indian Indices have remained below the dotted line in the morning trading session. Majority of sectoral indices are trading weak with realty and metal stocks being the leading losers in the pack. Only stocks from consumer durables and software sectors are trading in green today.

The BSE-Sensex is trading down 67 points. The NSE-Nifty is trading down 22 points. However, the midcap and small cap stocks are in favour today. The BSE Mid Cap index is trading up 0.10% and the BSE Small Cap index is trading up 0.17%. The rupee is trading at 60.78 to the US dollar.

Most telecom stocks are trading lower today. Reliance Communication and Bharti Airtel are among the stocks leading the losers. As per a financial daily, the telecom regulator TRAI has criticised the M&A norms in the sector. TRAI Chairman Rahul Khullar has said that the norms issued by the Department of Telecom (DoT) six months ago, were a non-starter and would not encourage consolidation in the sector. Since the new rules came into effect, there has been no M&A in the sector. The key hurdle is the contentious clause that requires the buyer to pay full market price for the spectrum that the seller possesses. This will certainly raise the cost of acquisition. The DoT has yet to come out with its final decision on the issue.

MNC pharma stocks are trading in green, with Sanofi India and GSK pharma are in demand. While Indian pharma companies are trading mixed with Torrent pharma and Piramal being the leading gainers in the pack. Dishman and JB chemicals are facing selling pressures. As per the financial daily, the national pricing pharmaceutical authority (NPPA) of India, has withdrawn the price control order on 108 drugs. Some time back, NPPA's order had broadened the scope of price control even to drugs outside of the National list of essential medicines (NLEM). The order was to cap prices of a list of 108 cardiovascular and diabetes drugs, not part of NLEM. This had created uproar from the industry, which also led to several lawsuits filing contesting the order of reducing the prices. However now the authorities have decided to withdraw this order and hence the notification given during the July 2014 order ceases to be valid. Among the various companies, Sanofi India had large part of its portfolio exposed in cardiac and diabetes therapies and was expected to get impacted the most. Among the other pharma companies viz; Abbott India, Cipla, Sun pharma, Ranbaxy, Lupin were also expected to get impacted on the back of this event. This new order of withdrawal will be a big relief for the pharma players, especially for Sanofi whose revenues were expected to get impacted the most.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Small and mid caps in favour today". Click here!


Views on News

Inflation & Your Investments (Fast Profits Daily)

Mar 4, 2021

Inflation is the buzz word in the world of finance these days. It impacts all of us. Here's how it affects your investments.

What India's Positive GDP Reading Means for Your Equity Mutual Fund Investments (Outside View)

Mar 4, 2021

Given the risks involved, we may witness a sort of 'W-shaped' recovery wherein we would dip again before moving up, explains Rounaq Neroy in this edition of the Daily Wealth Letter.

I'm Back to Where It All Started (Profit Hunter)

Mar 4, 2021

Join us in welcoming research analyst, Aditya Vora, to Equitymaster.

Dollar at 80? (Fast Profits Daily)

Mar 3, 2021

Can the rupee depreciate to 80 against the US dollar? In this video, I'll show you what the charts say.

Motilal Oswal Asset Allocation Passive Fund of Fund: Aims to Benefit from Investing in Multi-Asset Passive Funds (Outside View)

Mar 3, 2021

PersonalFN analyses the features of Motilal Oswal Asset Allocation Passive Fund of Fund and explains the potential this fund has to offer to its investors.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


Mar 4, 2021 (Close)